Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts. | Mol Ther Methods Clin Dev | 2024 | 39655308 | PubTator, text mining | PubMed |
| Comprehensive copy number analysis of spinal muscular atrophy among the Iranian population. | Sci Rep | 2024 | 39622884 | PubTator, text mining | PubMed |
| Comparison of the Mitophagy and Apoptosis Related Gene Expressions in Waste Embryo Culture Medium of Female Infertility Types. | Life (Basel) | 2024 | 39598305 | PubTator, text mining | PubMed |
| Development and validation of a one-step SMN assay for genetic testing in spinal muscular atrophy via MALDI-TOF MS. | Analyst | 2024 | 39584662 | PubTator, text mining | PubMed |
| A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based study. | Lancet Reg Health West Pac | 2024 | 39559164 | PubTator, text mining | PubMed |
| Insights into the Mode and Mechanism of Interactions Between RNA and RNA-Binding Proteins. | Int J Mol Sci | 2024 | 39518890 | PubTator, text mining | PubMed |
| SMN2 Copy Number Association with Spinal Muscular Atrophy Severity: Insights from Colombian Patients. | J Clin Med | 2024 | 39518541 | PubTator, text mining | PubMed |
| Treatment of spinal muscular atrophy. | Curr Opin Pediatr | 2024 | 39509253 | PubTator, text mining | PubMed |
| SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan. | BMC Med Genomics | 2024 | 39506867 | PubTator, text mining | PubMed |
| Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies. | Arq Neuropsiquiatr | 2024 | 39505005 | PubTator, text mining | PubMed |
| Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy. | Cell Mol Neurobiol | 2024 | 39463208 | PubTator, text mining | PubMed |
| Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study. | Lancet Reg Health Eur | 2024 | 39434961 | PubTator, text mining | PubMed |
| Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale Expanded. | Eur J Neurol | 2024 | 39392101 | PubTator, text mining | PubMed |
| Complex genetic variation in nearly complete human genomes. | bioRxiv | 2024 | 39372794 | PubTator, text mining | PubMed |
| Outcomes of early-treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study. | Muscle Nerve | 2024 | 39370660 | PubTator, text mining | PubMed |
| Recent Advance in Disease Modifying Therapies for Spinal Muscular Atrophy. | Acta Neurol Taiwan | 2024 | 39363429 | PubTator, text mining | PubMed |
| Decoding biology with massively parallel reporter assays and machine learning. | Genes Dev | 2024 | 39362779 | PubTator, text mining | PubMed |
| Evaluating the clinical efficacy of a long-read sequencing-based approach for carrier screening of spinal muscular atrophy. | Hum Genomics | 2024 | 39343938 | PubTator, text mining | PubMed |
| Onasemnogene-abeparvovec administration to premature infants with spinal muscular atrophy. | Ann Clin Transl Neurol | 2024 | 39342433 | PubTator, text mining | PubMed |
| A Machine Vision Method for Identifying Blade Tip Clearance in Wind Turbines. | Sensors (Basel) | 2024 | 39338680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=13